Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile.

Dabir S, Mohankumar A, Khatri MG, Rajan M

Open source

DOI
10.4103/ijo.ijo_927_23
Published
2024 Jan 1
Container
Indian journal of ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/ijo.ijo_927_23,
  title = {Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile.},
  author = {Dabir S and Mohankumar A and Khatri MG and Rajan M},
  year = {2024},
  journal = {Indian journal of ophthalmology},
  doi = {10.4103/ijo.ijo_927_23},
  url = {https://doi.org/10.4103/ijo.ijo_927_23}
}

RIS

TY  - JOUR
TI  - Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile.
AU  - Dabir S
AU  - Mohankumar A
AU  - Khatri MG
AU  - Rajan M
PY  - 2024
JO  - Indian journal of ophthalmology
DO  - 10.4103/ijo.ijo_927_23
UR  - https://doi.org/10.4103/ijo.ijo_927_23
ER  - 

APA

S, D., A, M., MG, K., & M, R. (2024). Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile.. Indian journal of ophthalmology. https://doi.org/10.4103/ijo.ijo_927_23

Source records